Since the overexpression of genes such as AXL and FOSL1 plays an important role in resistance to traditional therapies in melanoma and other types of tumors, part of the scientific research has focused on the regulatory mechanisms activated upstream by non-coding RNAs. This evidence concerns the gene FOSL1 and melanoma.